PM Modi’s visit serves as great inspiration to our team, says Bharat Biotech
First Published: 28th November, 2020 17:44 IST
Bharat Biotech on Saturday said Prime Minister Narendra Modi’s visit to their manufacturing facility in Genome Valley earlier on Saturday served as a great inspiration for the team and further
Bharat Biotech on Saturday said Prime Minister Narendra Modi’s visit to their manufacturing facility in Genome Valley earlier on Saturday served as a great inspiration for the team and further reinforced their commitment towards scientific discovery.
“The Prime Minister’s visit served as a great inspiration to our team, and further reinforces our commitment towards scientific discovery, solving public health issues, and the nation’s fight against COVID-19,” Bharat Biotech said in a statement.
Biotech is collaborating with the Indian Council of Medical Research (ICMR) for indigenous Covid-19 vaccine ‘Covaxin’ using the virus strain isolated by ICMR’s National Institute of Virology (NIV) based in Pune. Covaxin is currently undergoing Phase III trials.
“Covaxin is India’s first indigenous vaccine undergoing Phase III clinical trials as of now. It is the first, largest, and the only efficacy trial in the developing world, involving a large number of volunteers across 25 sites. The Covaxin Phase III trial is being conducted across India with 26,000 participants. The vaccine will be produced in one-of-its-kind Biosafety Level 3 production facility in the world,” Bharat Biotech said.
PM Modi visited the Biotech facility in Genome Valley of Shamirpet on the outskirts of Hyderabad and reviewed the development of its indigenous Covid-19 vaccine candidate, Covaxin. He was briefed by the Bharat Biotech founder and chairman Krishna Ella, and other scientists about developments in this regard.
“At the Bharat Biotech facility in Hyderabad, was briefed about their indigenous COVID-19 vaccine. Congratulated the scientists for their progress in the trials so far. Their team is closely working with ICMR to facilitate speedy progress,” PM Modi wrote on Twitter.
The Indian vaccine company in a tweet said: “Bharat Biotech is humbled and truly grateful to the man behind ‘Atmanirbhar Bharat’ for his motivation.”
The Prime Minister drove down to the plant from the Hakimpet Air Force Station, where he arrived around 1 pm from Ahmedabad and was received by Telangana Chief Secretary Somesh Kumar. (ANI)
COMMENTS
TOPMOST STORY NOW
Live Tripura Shocker: Professor Kicked, Punched and Abused By Students and Residents
12th April 2025
Live Sikkim: 13-year-old Sexually Assaulted Multiple Times by Multiple People since 2024
12th April 2025
Live Tipra Motha Chief Welcomes Centre’s Move to End Bangladesh Trans-Shipment
12th April 2025
Live NEHU Staff, Teachers Extend Full Support to Acting VC Prof. Sherwin Sungoh
12th April 2025
WE RECOMMEND
Assam CM Sarma Lauds Scrapping of Bangladesh Transhipment, Calls It a Big Boost for NE Security
He also described the decision as a reflection of the government’s commitment to protect the country’s “strategic and economic priorities”.
11th April 2025
Inside ‘Operation Rana’ – A High-Stakes, Top-Secret Extradition Mission
To ensure Rana's safety--and prevent any self-harm--one NIA official reportedly held his hand throughout the journey
11th April 2025
Who is Tahawwur Rana, Key Accused in 26/11 Mumbai Attacks, Extradited from the US Today?
Tahawwur Rana's extradition was confirmed in February this year when US President Donald Trump announced he would be handed over to India.
10th April 2025
NIA arrests 26/11 Mumbai terror attacks accused Tahawwur Rana on arrival at Delhi airport
NIA had secured Tahawwur Rana's extradition following years of sustained and concerted efforts
10th April 2025
Will ensure judicial integrity: NDBA’s statement before Tahawwur Rana’s trial
Tahawwur Rana is being brought to India for trial after the US Supreme Court rejected his plea to stay his extradition, exhausting all judicial options.
10th April 2025